Study estimates potential for ranibizumab to prevent blindness from age-related macular degeneration

A computer modeling study suggests that administering the drug ranibizumab is associated with reducing the magnitude of legal blindness and visual impairment caused by age-related macular degeneration in non-Hispanic white individuals, according to a new study.

Read the whole article on Science Daily

More from Science Daily